Literature DB >> 31570041

Assessment of a white matter reference region for 11C-UCB-J PET quantification.

Samantha Rossano1,2, Takuya Toyonaga1, Sjoerd J Finnema1, Mika Naganawa1, Yihuan Lu1, Nabeel Nabulsi1, Jim Ropchan1, Steven De Bruyn3, Christian Otoul3, Armel Stockis3, Jean-Marie Nicolas3, Paul Martin3, Joel Mercier3, Yiyun Huang1, R Paul Maguire3, Richard E Carson1,2.   

Abstract

11C-UCB-J is a positron emission tomography (PET) radioligand that has been used in humans for synaptic vesicle glycoprotein 2A (SV2A) imaging and as a potential synaptic density marker. The centrum semiovale (CS) is a proposed reference region for noninvasive quantification of 11C-UCB-J, due to negligible concentrations of SV2A in this region in baboon brain assessed by in vitro methods. However, in displacement scans with SV2A-specific drug levetiracetam in humans, a decrease in 11C-UCB-J concentration was observed in the CS, consistent with some degree of specific binding. The current study aims to validate the CS as a reference region by (1) optimizing CS region of interest (ROI) to minimize spill-in from gray matter with high radioactivity concentrations; (2) investigating convergence of CS ROI values using ordered subset expectation maximization (OS-EM) reconstruction, and (3) comparing baseline CS volume of distribution (VT) to nondisplaceable uptake in gray matter, VND. Improving ROI definition and increasing OS-EM iterations during reconstruction decreased the difference between CS VT and VND. However, even with these corrections, CS VT overestimated VND by ∼35-40%. These measures showed significant correlation, suggesting that, though biased, the CS may be a useful estimate of nondisplaceable uptake, allowing for noninvasive quantification for SV2A PET.

Entities:  

Keywords:  Ordered subset expectation maximization reconstruction; positron emission tomography; reference region; synaptic density; synaptic vesicle glycoprotein 2A

Year:  2019        PMID: 31570041      PMCID: PMC7446568          DOI: 10.1177/0271678X19879230

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  25 in total

Review 1.  Neuronal and glial cell biology.

Authors:  B A Barres; Y Barde
Journal:  Curr Opin Neurobiol       Date:  2000-10       Impact factor: 6.627

2.  Experimental and clinical evaluation of iterative reconstruction (OSEM) in dynamic PET: quantitative characteristics and effects on kinetic modeling.

Authors:  R Boellaard; A van Lingen; A A Lammertsma
Journal:  J Nucl Med       Date:  2001-05       Impact factor: 10.057

3.  Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates.

Authors:  Songye Li; Zhengxin Cai; Xiaoai Wu; Daniel Holden; Richard Pracitto; Michael Kapinos; Hong Gao; David Labaree; Nabeel Nabulsi; Richard E Carson; Yiyun Huang
Journal:  ACS Chem Neurosci       Date:  2018-11-16       Impact factor: 4.418

4.  Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue.

Authors:  Michel Koole; June van Aalst; Martijn Devrome; Nathalie Mertens; Kim Serdons; Brigitte Lacroix; Joel Mercier; David Sciberras; Paul Maguire; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-18       Impact factor: 9.236

Review 5.  A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology.

Authors:  Kjell Erlandsson; Irène Buvat; P Hendrik Pretorius; Benjamin A Thomas; Brian F Hutton
Journal:  Phys Med Biol       Date:  2012-10-16       Impact factor: 3.609

6.  Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography.

Authors:  R E Carson; M A Channing; R G Blasberg; B B Dunn; R M Cohen; K C Rice; P Herscovitch
Journal:  J Cereb Blood Flow Metab       Date:  1993-01       Impact factor: 6.200

7.  A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam.

Authors:  Carola Stockburger; Davide Miano; Marion Baeumlisberger; Thea Pallas; Tabiwang N Arrey; Michael Karas; Kristina Friedland; Walter E Müller
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

8.  Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.

Authors:  Erwin A van Vliet; Eleonora Aronica; Sandra Redeker; Karin Boer; Jan A Gorter
Journal:  Epilepsia       Date:  2008-08-19       Impact factor: 5.864

9.  Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.

Authors:  Nabeel B Nabulsi; Joël Mercier; Daniel Holden; Stephane Carré; Soheila Najafzadeh; Marie-Christine Vandergeten; Shu-Fei Lin; Anand Deo; Nathalie Price; Martyn Wood; Teresa Lara-Jaime; Florian Montel; Marc Laruelle; Richard E Carson; Jonas Hannestad; Yiyun Huang
Journal:  J Nucl Med       Date:  2016-02-04       Impact factor: 10.057

10.  A single-center, open-label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers.

Authors:  Sjoerd J Finnema; Samantha Rossano; Mika Naganawa; Shannan Henry; Hong Gao; Richard Pracitto; Ralph P Maguire; Joël Mercier; Sophie Kervyn; Jean-Marie Nicolas; Henrik Klitgaard; Steven DeBruyn; Christian Otoul; Paul Martin; Pierandrea Muglia; David Matuskey; Nabeel B Nabulsi; Yiyun Huang; Rafal M Kaminski; Jonas Hannestad; Armel Stockis; Richard E Carson
Journal:  Epilepsia       Date:  2019-03-29       Impact factor: 5.864

View more
  32 in total

1.  Lower prefrontal cortical synaptic vesicle binding in cocaine use disorder: An exploratory 11 C-UCB-J positron emission tomography study in humans.

Authors:  Gustavo A Angarita; Patrick D Worhunsky; Mika Naganawa; Takuya Toyonaga; Nabeel B Nabulsi; Chiang-Shan R Li; Irina Esterlis; Patrick D Skosnik; Rajiv Radhakrishnan; Brian Pittman; Ralitza Gueorguieva; Marc N Potenza; Sjoerd J Finnema; Yiyun Huang; Richard E Carson; Robert T Malison
Journal:  Addict Biol       Date:  2021-12-01       Impact factor: 4.280

2.  Association of entorhinal cortical tau deposition and hippocampal synaptic density in older individuals with normal cognition and early Alzheimer's disease.

Authors:  Adam P Mecca; Ming-Kai Chen; Ryan S O'Dell; Mika Naganawa; Takuya Toyonaga; Tyler A Godek; Joanna E Harris; Hugh H Bartlett; Wenzhen Zhao; Emmie R Banks; Gessica S Ni; Kelly Rogers; Jean Dominique Gallezot; Jim Ropchan; Paul R Emery; Nabeel B Nabulsi; Brent C Vander Wyk; Amy F T Arnsten; Yiyun Huang; Richard E Carson; Christopher H van Dyck
Journal:  Neurobiol Aging       Date:  2021-11-20       Impact factor: 4.673

3.  Changes in synaptic density in the subacute phase after ischemic stroke: A 11C-UCB-J PET/MR study.

Authors:  Laura Michiels; Nathalie Mertens; Liselot Thijs; Ahmed Radwan; Stefan Sunaert; Mathieu Vandenbulcke; Geert Verheyden; Michel Koole; Koen Van Laere; Robin Lemmens
Journal:  J Cereb Blood Flow Metab       Date:  2021-09-22       Impact factor: 6.960

4.  Imaging the fetal nonhuman primate brain with SV2A positron emission tomography (PET).

Authors:  Samantha Rossano; Takuya Toyonaga; Eric Berg; Isabella Lorence; Krista Fowles; Nabeel Nabulsi; Jim Ropchan; Songye Li; Yunpeng Ye; Zachary Felchner; David Kukis; Yiyun Huang; Helene Benveniste; Alice F Tarantal; Stephanie Groman; Richard E Carson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-05-28       Impact factor: 10.057

5.  A synergistic core for human brain evolution and cognition.

Authors:  Andrea I Luppi; Pedro A M Mediano; Fernando E Rosas; Negin Holland; Tim D Fryer; John T O'Brien; James B Rowe; David K Menon; Daniel Bor; Emmanuel A Stamatakis
Journal:  Nat Neurosci       Date:  2022-05-26       Impact factor: 28.771

6.  Comparison of [11C]UCB-J and [18F]FDG PET in Alzheimer's disease: A tracer kinetic modeling study.

Authors:  Ming-Kai Chen; Adam P Mecca; Mika Naganawa; Jean-Dominique Gallezot; Takuya Toyonaga; Jayanta Mondal; Sjoerd J Finnema; Shu-Fei Lin; Ryan S O'Dell; Julia W McDonald; Hannah R Michalak; Brent Vander Wyk; Nabeel B Nabulsi; Yiyun Huang; Amy Ft Arnsten; Christopher H van Dyck; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2021-03-24       Impact factor: 6.200

7.  In vivo synaptic density relates to glucose metabolism at rest in healthy subjects, but is strongly modulated by regional differences.

Authors:  June van Aalst; Jenny Ceccarini; Stefan Sunaert; Patrick Dupont; Michel Koole; Koen Van Laere
Journal:  J Cereb Blood Flow Metab       Date:  2021-01-14       Impact factor: 6.200

8.  In vivo evidence of lower synaptic vesicle density in schizophrenia.

Authors:  Rajiv Radhakrishnan; Patrick D Skosnik; Mohini Ranganathan; Mika Naganawa; Takuya Toyonaga; Sjoerd Finnema; Ansel T Hillmer; Irina Esterlis; Yiyun Huang; Nabeel Nabulsi; Richard E Carson; Deepak C D'Souza
Journal:  Mol Psychiatry       Date:  2021-06-16       Impact factor: 13.437

9.  Synaptic density in carriers of C9orf72 mutations: a [11 C]UCB-J PET study.

Authors:  Maura Malpetti; Negin Holland; P Simon Jones; Rong Ye; Thomas E Cope; Tim D Fryer; Young T Hong; George Savulich; Timothy Rittman; Luca Passamonti; Elijah Mak; Franklin I Aigbirhio; John T O'Brien; James B Rowe
Journal:  Ann Clin Transl Neurol       Date:  2021-06-16       Impact factor: 5.430

10.  In vivo coupling of dendritic complexity with presynaptic density in primary tauopathies.

Authors:  Elijah Mak; Negin Holland; P Simon Jones; George Savulich; Audrey Low; Maura Malpetti; Sanne S Kaalund; Luca Passamonti; Timothy Rittman; Rafael Romero-Garcia; Roido Manavaki; Guy B Williams; Young T Hong; Tim D Fryer; Franklin I Aigbirhio; John T O'Brien; James B Rowe
Journal:  Neurobiol Aging       Date:  2021-01-30       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.